Back to search
Cardiovascular Disease in Obstructive Sleep Apnea
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cardiovascular Disease in Obstructive Sleep Apnea trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cardiovascular Disease in Obstructive Sleep Apnea trials you may qualify forThe main goal of this prospective pre-post implementation study is to investigate how a structured testing and treatment program for obstructive sleep apnea usi…
A prospective double blind, placebo-controlled, randomized cross-over trial to evaluate the effect of lowering cerebral blood flow on the ventilatory chemorefle…
Ischemia and reperfusion (I/R) injury during abdominal aortic aneurysm (AAA) repair is inevitable and may lead to postoperative multi-organ failure. Remote isch…
Obstructive sleep apnea syndrome (OSAS) is characterized by partial (hypopnea) or complete (apnea) obstruction of the upper airways, leading to intermittent hyp…
The investigators hypothesize that Obstructive Sleep Apnea (OSA) is an independent risk factor for atrial fibrosis development. The investigators aim to prove t…
Obstructive sleep apnea (OSA) is a prevalent condition that significantly impacts the sleep health and overall well-being of millions of adults worldwide. It is…
People with type 2 diabetes are at risk of complications linked with high blood sugars and these are monitored for in healthcare appointments. However, people w…
The goal of this randomized clinical trial was to evaluate the effects of empagliflozin, a sodium-glucose cotransporter-2 inhibitor (SGLT2i) on sleep and cardia…
Atrial fibrillation (AF) is one of the most common clinical arrhythmias. Catheter ablation is an effective therapeutic strategy; however, recurrence rates remai…